This information on this website is provided by AstraZeneca for educational purposes only and this site is intended for Non-UK and Non-US healthcare professionals only. It should not be used for diagnosing or treating a health problem or disease.
Through earlier diagnosis and intervention, you play a crucial role in driving better outcomes for your patients, including those who may be at risk of CKD.1,2 Here you will find a selection of resources to support you and your patients.
Leading experts explain the importance of diagnosing CKD early.
IN THIS SERIES
Early diagnosis really mattersDr Ana Cebrian (3:53)
Discover from Dr A Cebrian why early diagnosis of CKD matters and how you can make a difference for your patients
Primary care: intervene early to make a differenceProf. Christoph Wanner and Prof. Sam Seidu (5:06)
Watch Profs. Christoph Wanner and Sam Seidu explain why early diagnosis in primary care is so important
ISN-KDIGO-PCDE-WONCA Quick QuideProf. Pinar Topsever (6:19)
Watch Prof. P Topsever walk through using the KDIGO heatmap
The diabetic patient is at risk of CKDProf. Xavier Cos (4:00)
Prof. Xavier Cos explains more about the risk of CKD in your patients with type 2 diabetes
Screening for CKD using both eGFR and UACRProf. Reinhold Kreutz (4:03)
Discover from Prof. R Kreutz how UACR and eGFR work together to help you screen for CKD in your patients
Hear from Prof. Reinhold Kreutz what you can do to help your patients with hypertension who might also be at risk of CKD
Hear from Prof. Reinhold Kreutz what you can do to help your patients with hypertension who might also be at risk of CKD
Help your patients who are at risk of CKD (or have been recently diagnosed with
CKD) understand what they can do to improve outcomes.
Click here to see the ISN CKD Early Identification and Intervention in Primary Care one-pager.
View
Understanding risk of progression
Explore how eGFR and UACR work together to help you get the complete picture of CKD diagnosis and progression3,4
Companion Video
Talking to patients early helps them to avoid surprises later. So when you notice a drop in eGFR or an increase in UACR and suspect CKD, it's time to kick off a conversation.
CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; KDIGO, Kidney Disease: Improving Global Outcomes; UACR, urine albumin-creatinine ratio
The information on this website is provided by AstraZeneca for educational purposes only and this site is intended for Non-UK and Non-US healthcare professionals only.
It should not be used for diagnosing or treating a health problem or disease.
By clicking the link below, you declare and confirm that you are a Non-US and Non-UK healthcare professional.
The website is intended for Non-UK and Non-US healthcare professionals only. Please speak to your healthcare provider if you require further information about the burden of CKD.
If you are a member of the press, you should contact
the AstraZeneca press office.Email: global-mediateam@astrazeneca.com
Tel: +44 (0)1223 344 800